- Investing Ideas
- Canadian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Canadian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
4
1 new
Mid-Large Cap Stocks
4 companies
Curaleaf Holdings
Market Cap: CA$2.9b
Engages in the retail and wholesale of cannabis products in the United States and internationally.
CURA
CA$4.16
7D
25.3%
1Y
249.6%
Cronos Group
Market Cap: CA$1.4b
A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
New
CRON
CA$3.78
7D
5.9%
1Y
58.8%
Green Thumb Industries
Market Cap: CA$2.1b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$9.79
7D
5.3%
1Y
35.6%
Trulieve Cannabis
Market Cap: CA$1.7b
Operates as a cannabis retailer in the United States.
TRUL
CA$9.58
7D
10.0%
1Y
84.9%